SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-May-24 4:30 PM View: | Lensar, Inc. (LNSR) | 07-May-24 | Grant | 22,000 | -- | -- | 107% 20.57K to 42.57K | |
24-Aug-23 8:52 PM View: | Geron Corp (GERN) | 24-Aug-23 | Purchase | 6,607 | $2.28 | $15,064.00 | 32% 20.44K to 27.05K | |
24-Aug-23 8:52 PM View: | Geron Corp (GERN) | 24-Aug-23 | Purchase | 6,579 | $2.28 | $15,000.10 | 24% 27.05K to 33.63K | |
30-May-23 5:01 PM View: | Lensar, Inc. (LNSR) | 25-May-23 | Grant | 9,288 | -- | -- | 82% 11.29K to 20.57K | |
27-May-22 9:24 PM View: | Lensar, Inc. (LNSR) | 25-May-22 | Grant | 4,285 | -- | -- | 61% 7.0K to 11.29K | |
24-Nov-20 7:25 PM View: | PDL BioPharma Inc. (PDLI) | 23-Nov-20 | Market Sale | 25,826 | $2.44 | $63,015.40 | (100%) 25.83K to 0 | (11%) |
20-Nov-20 8:22 PM View: | PDL BioPharma Inc. (PDLI) | 18-Nov-20 | Market Sale | 63,291 | $2.38 | $150,696.00 | (71%) 89.12K to 25.83K | (14%) |
24-Aug-20 8:57 PM View: | Geron Corp (GERN) | 21-Aug-20 | Market Purchase | 17,441 | $1.73 | $30,172.90 | 793% 2.2K to 19.64K | |
24-Aug-20 6:05 AM View: | PDL BioPharma Inc. (PDLI) | 19-Aug-20 | Grant | 25,826 | -- | -- | 41% 63.29K to 89.12K | |
13-Jan-20 9:10 PM View: | Geron Corp (GERN) | 10-Jan-20 | Market Purchase | 800 | $1.35 | $1,080.00 | 100% 0 to 0.8K | |
13-Jan-20 9:10 PM View: | Geron Corp (GERN) | 10-Jan-20 | Market Purchase | 2,200 | $1.34 | $2,948.00 | 275% 0.8K to 3.0K | |
25-Jun-18 4:10 PM View: | PDL BioPharma Inc. (PDLI) | 22-Jun-18 | Grant | 63,291 | $2.37 | $150,000.00 | 100% 0 to 63.29K | 12% |